Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Clinical Oncology|December 10, 2024
Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitorsYasutaka Yamada, Kodai Sato, Shinichi Sakamoto, et al.
Prostate International|April 11, 2025
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancerYasutaka Yamada, Shinichi Sakamoto, Takuya Tsujino, et al.
Elife|June 22, 2021
Restored TDCA and valine levels imitate the effects of bariatric surgeryMarkus Quante, Jasper Iske, Timm Heinbokel, et al.
Cancer Medicine|September 14, 2023
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancerTakuya Tsujino, Satoshi Tokushige, Kazumasa Komura, et al.
Molecular Cancer|November 19, 2023
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder CancerKazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, et al.
Anticancer Research|September 26, 2025
Real-world Outcomes of Enfortumab Vedotin in Elderly Patients With Metastatic Urothelial CarcinomaKyosuke Nishio, Kensuke Hirosuna, Taizo Uchimoto, et al.
Japanese Journal of Clinical Oncology|February 3, 2026
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxelTaizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, et al.
World Journal of Urology|November 4, 2023
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinomaTakuya Tsujino, Kazumasa Komura, Teruo Inamoto, et al.
The Prostate|March 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI TherapyTakeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda, et al.
Japanese Journal of Clinical Oncology|October 19, 2025
Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan ConsortiumTaizo Uchimoto, Kensuke Hirosuna, Heima Niigawa, et al.
Pageof 7